Patologie del cuoio capelluto

Translated title of the contribution: Scalp disorders

Antonio Di Maio, Damiano Abeni, Gianfranco Altomare, Enzo Berardesca, Piergiacomo Calzavara Pinton, Clara De Simone, Alberto Giannetti, Paolo Gisondi, Torello Lotti, Stefano Piaserico, Rosita Saraceno, Gino Antonio Vena

Research output: Contribution to journalArticle

Abstract

An international meeting on scalp disorders was recently held in Rome. Psoriasis, seborrheic dermatitis, sebopsoriasis and primary cicatricial alopecias were the main topics. In this circumstance the results of the clinical trials in scalp psoriasis with a new fixed combination containing calcipotriene 50 μg/g and betamethasone (0.5 mg/g) as dipropionate in lipophilic gel (Xamiol®) were shown. Calcipotriene plus betamethasone dipropionate gel is a fast-acting, very efficacious, safe, oncedaily treatment for scalp psoriasis ranging from mild to very severe. It is more efficacious than calcipotriene, betamethasone dipropionate and the gel vehicle. The safety profile is similar to that of betamethasone dipropionate and better than calcipotriol. Two 52-week studies have shown that calcipotriene plus betamethasone dipropionate gel can be safely used longterm.

Original languageItalian
Pages (from-to)71-81
Number of pages11
JournalJournal of Plastic Dermatology
Volume6
Issue number1
Publication statusPublished - 2010

Fingerprint

Scalp
Psoriasis
Gels
Seborrheic Dermatitis
Betamethasone
Alopecia
calcipotriene
Clinical Trials
Safety
betamethasone-17,21-dipropionate

ASJC Scopus subject areas

  • Dermatology

Cite this

Di Maio, A., Abeni, D., Altomare, G., Berardesca, E., Pinton, P. C., De Simone, C., ... Vena, G. A. (2010). Patologie del cuoio capelluto. Journal of Plastic Dermatology, 6(1), 71-81.

Patologie del cuoio capelluto. / Di Maio, Antonio; Abeni, Damiano; Altomare, Gianfranco; Berardesca, Enzo; Pinton, Piergiacomo Calzavara; De Simone, Clara; Giannetti, Alberto; Gisondi, Paolo; Lotti, Torello; Piaserico, Stefano; Saraceno, Rosita; Vena, Gino Antonio.

In: Journal of Plastic Dermatology, Vol. 6, No. 1, 2010, p. 71-81.

Research output: Contribution to journalArticle

Di Maio, A, Abeni, D, Altomare, G, Berardesca, E, Pinton, PC, De Simone, C, Giannetti, A, Gisondi, P, Lotti, T, Piaserico, S, Saraceno, R & Vena, GA 2010, 'Patologie del cuoio capelluto', Journal of Plastic Dermatology, vol. 6, no. 1, pp. 71-81.
Di Maio A, Abeni D, Altomare G, Berardesca E, Pinton PC, De Simone C et al. Patologie del cuoio capelluto. Journal of Plastic Dermatology. 2010;6(1):71-81.
Di Maio, Antonio ; Abeni, Damiano ; Altomare, Gianfranco ; Berardesca, Enzo ; Pinton, Piergiacomo Calzavara ; De Simone, Clara ; Giannetti, Alberto ; Gisondi, Paolo ; Lotti, Torello ; Piaserico, Stefano ; Saraceno, Rosita ; Vena, Gino Antonio. / Patologie del cuoio capelluto. In: Journal of Plastic Dermatology. 2010 ; Vol. 6, No. 1. pp. 71-81.
@article{c863b62707e248da9bd5c7c6e6f8a361,
title = "Patologie del cuoio capelluto",
abstract = "An international meeting on scalp disorders was recently held in Rome. Psoriasis, seborrheic dermatitis, sebopsoriasis and primary cicatricial alopecias were the main topics. In this circumstance the results of the clinical trials in scalp psoriasis with a new fixed combination containing calcipotriene 50 μg/g and betamethasone (0.5 mg/g) as dipropionate in lipophilic gel (Xamiol{\circledR}) were shown. Calcipotriene plus betamethasone dipropionate gel is a fast-acting, very efficacious, safe, oncedaily treatment for scalp psoriasis ranging from mild to very severe. It is more efficacious than calcipotriene, betamethasone dipropionate and the gel vehicle. The safety profile is similar to that of betamethasone dipropionate and better than calcipotriol. Two 52-week studies have shown that calcipotriene plus betamethasone dipropionate gel can be safely used longterm.",
keywords = "Calcipotriene plus betamethasone dipropionate gel, Psoriasis, Scalp disorders",
author = "{Di Maio}, Antonio and Damiano Abeni and Gianfranco Altomare and Enzo Berardesca and Pinton, {Piergiacomo Calzavara} and {De Simone}, Clara and Alberto Giannetti and Paolo Gisondi and Torello Lotti and Stefano Piaserico and Rosita Saraceno and Vena, {Gino Antonio}",
year = "2010",
language = "Italian",
volume = "6",
pages = "71--81",
journal = "Journal of Plastic Dermatology",
issn = "2035-0686",
publisher = "International-Italian Society of Plastic and Oncologic Dermatology",
number = "1",

}

TY - JOUR

T1 - Patologie del cuoio capelluto

AU - Di Maio, Antonio

AU - Abeni, Damiano

AU - Altomare, Gianfranco

AU - Berardesca, Enzo

AU - Pinton, Piergiacomo Calzavara

AU - De Simone, Clara

AU - Giannetti, Alberto

AU - Gisondi, Paolo

AU - Lotti, Torello

AU - Piaserico, Stefano

AU - Saraceno, Rosita

AU - Vena, Gino Antonio

PY - 2010

Y1 - 2010

N2 - An international meeting on scalp disorders was recently held in Rome. Psoriasis, seborrheic dermatitis, sebopsoriasis and primary cicatricial alopecias were the main topics. In this circumstance the results of the clinical trials in scalp psoriasis with a new fixed combination containing calcipotriene 50 μg/g and betamethasone (0.5 mg/g) as dipropionate in lipophilic gel (Xamiol®) were shown. Calcipotriene plus betamethasone dipropionate gel is a fast-acting, very efficacious, safe, oncedaily treatment for scalp psoriasis ranging from mild to very severe. It is more efficacious than calcipotriene, betamethasone dipropionate and the gel vehicle. The safety profile is similar to that of betamethasone dipropionate and better than calcipotriol. Two 52-week studies have shown that calcipotriene plus betamethasone dipropionate gel can be safely used longterm.

AB - An international meeting on scalp disorders was recently held in Rome. Psoriasis, seborrheic dermatitis, sebopsoriasis and primary cicatricial alopecias were the main topics. In this circumstance the results of the clinical trials in scalp psoriasis with a new fixed combination containing calcipotriene 50 μg/g and betamethasone (0.5 mg/g) as dipropionate in lipophilic gel (Xamiol®) were shown. Calcipotriene plus betamethasone dipropionate gel is a fast-acting, very efficacious, safe, oncedaily treatment for scalp psoriasis ranging from mild to very severe. It is more efficacious than calcipotriene, betamethasone dipropionate and the gel vehicle. The safety profile is similar to that of betamethasone dipropionate and better than calcipotriol. Two 52-week studies have shown that calcipotriene plus betamethasone dipropionate gel can be safely used longterm.

KW - Calcipotriene plus betamethasone dipropionate gel

KW - Psoriasis

KW - Scalp disorders

UR - http://www.scopus.com/inward/record.url?scp=77954500304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954500304&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:77954500304

VL - 6

SP - 71

EP - 81

JO - Journal of Plastic Dermatology

JF - Journal of Plastic Dermatology

SN - 2035-0686

IS - 1

ER -